GREEN CACTUS SPICY SPECIAL SEASONING (SEA-903), Net Weight XXXX Lbs. -- FIRST SPICE MIXING COMPANY LONG ISLAND CITY, N.Y. --- INGREDIENTS...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1394-2015.
Firm was notified by immediate supplier that certain lots of ground cumin may have been contaminated with peanut protein which is not declared on the label.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1394-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact First Spice Mixing Co.,inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1394-2015.
First Spice Mixing Co.,Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
First Spice Mixing Co.,inc. Recall FAQ
First Spice Mixing Co.,inc. is the subject of a produce safety report: GREEN CACTUS SPICY SPECIAL SEASONING (SEA-903), Net Weight XXXX Lbs. -- FIRST SPICE MIXING COMPANY LONG ISLAND CITY, N.Y. --- INGREDIENTS.... The notice was published on December 24, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 1,007 units are potentially affected.